Pharmacopoeia Reference: United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type B. European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) monograph for Carbomers.
Pharmacopoeia Reference: United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type B, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) mongographs for Carbomers.
Pharmacopoeia Reference: United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type C. European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) monographs for Carbomers.
INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**